HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011

This article was originally published in The Tan Sheet

Executive Summary

Pfizer expects to unveil restructuring plans, including the potential divestiture of its Consumer Healthcare and Nutrition units, in the second half of 2011.

You may also be interested in...



Pfizer Will Unload Nutrition Division, Keep Consumer Product Unit

Pfizer will divest or spin off its nutrition unit but the firm will keep its consumer product business and look into future OTC switches.

Pfizer Consumer Chief Sees Chronic Conditions In OTC Future

Future OTC switches of drugs for chronic conditions like high cholesterol could "fundamentally help" alter the health care environment and lower costs, says Pfizer Consumer Healthcare President Paul Sturman.

Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era

Pfizer's election of Ian Read as president, CEO and director of the company sets the stage for a management transition at the firm, which has underperformed its peers on several measures in recent years.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134271

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel